+1 347 708 0418
The Early Cancer Detection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Early Cancer Detection size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Early Cancer Detection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Early Cancer Detection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ctDNA
CTC
Exosomes
Circulating protein
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
GRAIL(Illumina)
Exact Sciences
Guardant Health
BGI
New Horizon Health
Epigenomics AG
Genetron Health
Berry Genomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Early Cancer Detection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Early Cancer Detection, with revenue, gross margin and global market share of Early Cancer Detection from 2019 to 2021.
Chapter 3, the Early Cancer Detection competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Early Cancer Detection market forecast, by regions, tyepe and application
, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Early Cancer Detection research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Early Cancer Detection
1.2 Classification of Early Cancer Detection by Tyepe
1.2.1 Overview: Global Early Cancer Detection Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Early Cancer Detection Revenue Market Share by Type in 2020
1.2.3 ctDNA
1.2.4 CTC
1.2.5 Exosomes
1.2.6 Circulating protein
1.3 Global Early Cancer Detection Market by Application
1.3.1 Overview: Global Early Cancer Detection Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Early Cancer Detection Market Size & Forecast
1.5 Global Early Cancer Detection Market Size and Forecast by Region
1.5.1 Global Early Cancer Detection Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Early Cancer Detection Market Size by Region, (2016-2021)
1.5.3 North America Early Cancer Detection Market Size and Prospect (2016-2026)
1.5.4 Europe Early Cancer Detection Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Early Cancer Detection Market Size and Prospect (2016-2026)
1.5.6 South America Early Cancer Detection Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Early Cancer Detection Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Early Cancer Detection Market Drivers
1.6.2 Early Cancer Detection Market Restraints
1.6.3 Early Cancer Detection Trends Analysis
2 Company Profiles
2.1 GRAIL(Illumina)
2.1.1 GRAIL(Illumina) Details
2.1.2 GRAIL(Illumina) Major Business
2.1.3 GRAIL(Illumina) Early Cancer Detection Product and Solutions
2.1.4 GRAIL(Illumina) Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GRAIL(Illumina) Recent Developments and Future Plans
2.2 Exact Sciences
2.2.1 Exact Sciences Details
2.2.2 Exact Sciences Major Business
2.2.3 Exact Sciences Early Cancer Detection Product and Solutions
2.2.4 Exact Sciences Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Exact Sciences Recent Developments and Future Plans
2.3 Guardant Health
2.3.1 Guardant Health Details
2.3.2 Guardant Health Major Business
2.3.3 Guardant Health Early Cancer Detection Product and Solutions
2.3.4 Guardant Health Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Guardant Health Recent Developments and Future Plans
2.4 BGI
2.4.1 BGI Details
2.4.2 BGI Major Business
2.4.3 BGI Early Cancer Detection Product and Solutions
2.4.4 BGI Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BGI Recent Developments and Future Plans
2.5 New Horizon Health
2.5.1 New Horizon Health Details
2.5.2 New Horizon Health Major Business
2.5.3 New Horizon Health Early Cancer Detection Product and Solutions
2.5.4 New Horizon Health Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 New Horizon Health Recent Developments and Future Plans
2.6 Epigenomics AG
2.6.1 Epigenomics AG Details
2.6.2 Epigenomics AG Major Business
2.6.3 Epigenomics AG Early Cancer Detection Product and Solutions
2.6.4 Epigenomics AG Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Epigenomics AG Recent Developments and Future Plans
2.7 Genetron Health
2.7.1 Genetron Health Details
2.7.2 Genetron Health Major Business
2.7.3 Genetron Health Early Cancer Detection Product and Solutions
2.7.4 Genetron Health Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Genetron Health Recent Developments and Future Plans
2.8 Berry Genomics
2.8.1 Berry Genomics Details
2.8.2 Berry Genomics Major Business
2.8.3 Berry Genomics Early Cancer Detection Product and Solutions
2.8.4 Berry Genomics Early Cancer Detection Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Berry Genomics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Early Cancer Detection Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Early Cancer Detection Players Market Share
3.2.2 Top 10 Early Cancer Detection Players Market Share
3.2.3 Market Competition Trend
3.3 Early Cancer Detection Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Early Cancer Detection Revenue and Market Share by Type (2016-2021)
4.2 Global Early Cancer Detection Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Early Cancer Detection Revenue Market Share by Application (2016-2021)
5.2 Early Cancer Detection Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Early Cancer Detection Revenue by Type (2016-2026)
6.2 North America Early Cancer Detection Revenue by Application (2016-2026)
6.3 North America Early Cancer Detection Market Size by Country
6.3.1 North America Early Cancer Detection Revenue by Country (2016-2026)
6.3.2 United States Early Cancer Detection Market Size and Forecast (2016-2026)
6.3.3 Canada Early Cancer Detection Market Size and Forecast (2016-2026)
6.3.4 Mexico Early Cancer Detection Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Early Cancer Detection Revenue by Type (2016-2026)
7.2 Europe Early Cancer Detection Revenue by Application (2016-2026)
7.3 Europe Early Cancer Detection Market Size by Country
7.3.1 Europe Early Cancer Detection Revenue by Country (2016-2026)
7.3.2 Germany Early Cancer Detection Market Size and Forecast (2016-2026)
7.3.3 France Early Cancer Detection Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Early Cancer Detection Market Size and Forecast (2016-2026)
7.3.5 Russia Early Cancer Detection Market Size and Forecast (2016-2026)
7.3.6 Italy Early Cancer Detection Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Early Cancer Detection Revenue by Type (2016-2026)
8.2 Asia-Pacific Early Cancer Detection Revenue by Application (2016-2026)
8.3 Asia-Pacific Early Cancer Detection Market Size by Region
8.3.1 Asia-Pacific Early Cancer Detection Revenue by Region (2016-2026)
8.3.2 China Early Cancer Detection Market Size and Forecast (2016-2026)
8.3.3 Japan Early Cancer Detection Market Size and Forecast (2016-2026)
8.3.4 South Korea Early Cancer Detection Market Size and Forecast (2016-2026)
8.3.5 India Early Cancer Detection Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Early Cancer Detection Market Size and Forecast (2016-2026)
8.3.7 Australia Early Cancer Detection Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Early Cancer Detection Revenue by Type (2016-2026)
9.2 South America Early Cancer Detection Revenue by Application (2016-2026)
9.3 South America Early Cancer Detection Market Size by Country
9.3.1 South America Early Cancer Detection Revenue by Country (2016-2026)
9.3.2 Brazil Early Cancer Detection Market Size and Forecast (2016-2026)
9.3.3 Argentina Early Cancer Detection Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Early Cancer Detection Revenue by Type (2016-2026)
10.2 Middle East & Africa Early Cancer Detection Revenue by Application (2016-2026)
10.3 Middle East & Africa Early Cancer Detection Market Size by Country
10.3.1 Middle East & Africa Early Cancer Detection Revenue by Country (2016-2026)
10.3.2 Turkey Early Cancer Detection Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Early Cancer Detection Market Size and Forecast (2016-2026)
10.3.4 UAE Early Cancer Detection Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Early Cancer Detection Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Early Cancer Detection Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Early Cancer Detection Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Early Cancer Detection Revenue (USD Million) by Region (2016-2021)
Table 5. Global Early Cancer Detection Revenue Market Share by Region (2021-2026)
Table 6. GRAIL(Illumina) Corporate Information, Head Office, and Major Competitors
Table 7. GRAIL(Illumina) Major Business
Table 8. GRAIL(Illumina) Early Cancer Detection Product and Solutions
Table 9. GRAIL(Illumina) Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Exact Sciences Corporate Information, Head Office, and Major Competitors
Table 11. Exact Sciences Major Business
Table 12. Exact Sciences Early Cancer Detection Product and Solutions
Table 13. Exact Sciences Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Guardant Health Corporate Information, Head Office, and Major Competitors
Table 15. Guardant Health Major Business
Table 16. Guardant Health Early Cancer Detection Product and Solutions
Table 17. Guardant Health Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BGI Corporate Information, Head Office, and Major Competitors
Table 19. BGI Major Business
Table 20. BGI Early Cancer Detection Product and Solutions
Table 21. BGI Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. New Horizon Health Corporate Information, Head Office, and Major Competitors
Table 23. New Horizon Health Major Business
Table 24. New Horizon Health Early Cancer Detection Product and Solutions
Table 25. New Horizon Health Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Epigenomics AG Corporate Information, Head Office, and Major Competitors
Table 27. Epigenomics AG Major Business
Table 28. Epigenomics AG Early Cancer Detection Product and Solutions
Table 29. Epigenomics AG Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Genetron Health Corporate Information, Head Office, and Major Competitors
Table 31. Genetron Health Major Business
Table 32. Genetron Health Early Cancer Detection Product and Solutions
Table 33. Genetron Health Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Berry Genomics Corporate Information, Head Office, and Major Competitors
Table 35. Berry Genomics Major Business
Table 36. Berry Genomics Early Cancer Detection Product and Solutions
Table 37. Berry Genomics Early Cancer Detection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Early Cancer Detection Revenue (USD Million) by Players (2019-2021)
Table 39. Global Early Cancer Detection Revenue Share by Players (2019-2021)
Table 40. Breakdown of Early Cancer Detection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Early Cancer Detection Players Head Office, Products and Services Provided
Table 42. Early Cancer Detection Mergers & Acquisitions in the Past Five Years
Table 43. Early Cancer Detection New Entrants and Expansion Plans
Table 44. Global Early Cancer Detection Revenue (USD Million) by Type (2016-2021)
Table 45. Global Early Cancer Detection Revenue Share by Type (2016-2021)
Table 46. Global Early Cancer Detection Revenue Forecast by Type (2021-2026)
Table 47. Global Early Cancer Detection Revenue by Application (2016-2021)
Table 48. Global Early Cancer Detection Revenue Forecast by Application (2021-2026)
Table 49. North America Early Cancer Detection Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Early Cancer Detection Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Early Cancer Detection Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Early Cancer Detection Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Early Cancer Detection Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Early Cancer Detection Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Early Cancer Detection Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Early Cancer Detection Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Early Cancer Detection Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Early Cancer Detection Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Early Cancer Detection Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Early Cancer Detection Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Early Cancer Detection Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Early Cancer Detection Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Early Cancer Detection Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Early Cancer Detection Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Early Cancer Detection Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Early Cancer Detection Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Early Cancer Detection Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Early Cancer Detection Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Early Cancer Detection Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Early Cancer Detection Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Early Cancer Detection Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Early Cancer Detection Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Early Cancer Detection Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Early Cancer Detection Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Early Cancer Detection Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Early Cancer Detection Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Early Cancer Detection Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Early Cancer Detection Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Early Cancer Detection Picture
Figure 2. Global Early Cancer Detection Revenue Market Share by Tyepe in 2020
Figure 3. ctDNA
Figure 4. CTC
Figure 5. Exosomes
Figure 6. Circulating protein
Figure 7. Early Cancer Detection Revenue Market Share by Application
in 2020
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Others Picture
Figure 11. Global Early Cancer Detection Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Early Cancer Detection Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Early Cancer Detection Revenue Market Share by Region (2016-2026)
Figure 14. Global Early Cancer Detection Revenue Market Share by Region in 2020
Figure 15. North America Early Cancer Detection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Early Cancer Detection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Early Cancer Detection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Early Cancer Detection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Early Cancer Detection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Early Cancer Detection Market Drivers
Figure 21. Early Cancer Detection Market Restraints
Figure 22. Early Cancer Detection Market Trends
Figure 23. GRAIL(Illumina) Recent Developments and Future Plans
Figure 24. Exact Sciences Recent Developments and Future Plans
Figure 25. Guardant Health Recent Developments and Future Plans
Figure 26. BGI Recent Developments and Future Plans
Figure 27. New Horizon Health Recent Developments and Future Plans
Figure 28. Epigenomics AG Recent Developments and Future Plans
Figure 29. Genetron Health Recent Developments and Future Plans
Figure 30. Berry Genomics Recent Developments and Future Plans
Figure 31. Global Early Cancer Detection Revenue Share by Players in 2020
Figure 32. Early Cancer Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Early Cancer Detection Revenue Market Share in 2020
Figure 34. Global Top 10 Players Early Cancer Detection Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Early Cancer Detection Revenue Share by Type in 2020
Figure 37. Global Early Cancer Detection Market Share Forecast by Type (2021-2026)
Figure 38. Global Early Cancer Detection Revenue Share by Application in 2020
Figure 39. Global Early Cancer Detection Market Share Forecast by Application (2021-2026)
Figure 40. North America Early Cancer Detection Sales Market Share by Type (2016-2026)
Figure 41. North America Early Cancer Detection Sales Market Share by Application (2016-2026)
Figure 42. North America Early Cancer Detection Revenue Market Share by Country (2016-2026)
Figure 43. United States Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Early Cancer Detection Sales Market Share by Type (2016-2026)
Figure 47. Europe Early Cancer Detection Sales Market Share by Application (2016-2026)
Figure 48. Europe Early Cancer Detection Revenue Market Share by Country (2016-2026)
Figure 49. Germany Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Early Cancer Detection Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Early Cancer Detection Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Early Cancer Detection Revenue Market Share by Region (2016-2026)
Figure 57. China Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Early Cancer Detection Sales Market Share by Type (2016-2026)
Figure 64. South America Early Cancer Detection Sales Market Share by Application (2016-2026)
Figure 65. South America Early Cancer Detection Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Early Cancer Detection Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Early Cancer Detection Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Early Cancer Detection Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Early Cancer Detection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
Buy
